Advances in cellular therapy for cancer: vector design and genome editing
Immunology & Cell Biology · 2026-05 · 104 (5) · 490-493
DOI: 10.1111/imcb.70111 ↗At a glance
Übersichtsarbeit in Immunology & Cell Biology, published online on 2026-04-07. Written by Alexander Donald McLellan and 3 co-authors. Institution: Department of Microbiology & Immunology, The University of Otago, Dunedin, New Zealand. Major MEDLINE topics: Neoplasms, Gene Editing, Genetic Vectors, Immunotherapy, Adoptive. Cited 1 times so far (Crossref); 5 references.
Abstract (original language)
The year 2025 saw continued scientific progress in cell therapy and further commercial expansion of CAR T‐cell therapeutics, alongside notable strategic contractions driven largely by manufacturing cost constraints. The field also benefited from the recent transition in T‐cell subset nomenclature toward function‐ and state‐based definitions, enabling more precise characterization of CAR T‐cell products. We highlight five key advances, including in vivo CAR generation, next‐generation genome engineering and the expanding potential of AI‐guided antibody discovery platforms for cellular immunotherapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Microbiology & Immunology, The University of Otago, Dunedin, New Zealand.
- Department of Histology, Fakultas Kedokteran, Universitas Indonesia, Jakarta, Indonesia.
ORCID profiles: Alexander Donald McLellan
Cite
APA
McLellan, A. D., Dobson, L. J., Marron, P. W., & Pe, K. C. (2026). Advances in cellular therapy for cancer: vector design and genome editing. Immunology & Cell Biology, 104(5), 490-493. https://doi.org/10.1111/imcb.70111
Vancouver
McLellan AD, Dobson LJ, Marron PW, Pe KC. Advances in cellular therapy for cancer: vector design and genome editing. Immunology & Cell Biology. 2026;104(5):490-493. doi:10.1111/imcb.70111
BibTeX
@article{McLellan2026,
author = {McLellan, Alexander Donald and Dobson, Lachlan James and Marron, Patrick William and Pe, Kristine Cate},
title = {Advances in cellular therapy for cancer: vector design and genome editing},
journal = {Immunology & Cell Biology},
year = {2026},
volume = {104},
number = {5},
pages = {490--493},
doi = {10.1111/imcb.70111}
}
EUVIMED